Clinical Report: When Hemoglobin Signals Neonatal Risk
Overview
Maternal hemoglobin concentration in early pregnancy is significantly associated with severe neonatal morbidity and mortality (SNM-M). Both low and high hemoglobin levels increase the risk of adverse neonatal outcomes, highlighting the importance of monitoring hemoglobin during early gestation.
Background
Understanding the relationship between maternal hemoglobin levels and neonatal outcomes is crucial for improving maternal and infant health. This study, involving over a million births, provides evidence that both extremes of hemoglobin concentration can lead to increased risks of severe neonatal complications. These findings underscore the need for careful monitoring and potential interventions during early pregnancy.
Data Highlights
| Hemoglobin Level (g/L) | Adjusted Relative Risk of SNM-M | Rate of SNM-M (%) |
|---|---|---|
| 90 | 1.17 | 6.7 |
| 105 | 1.08 | 6.7 |
| 125 (reference) | - | 6.7 |
| 135 | 1.05 | 6.7 |
| 150 | 1.20 | 6.7 |
Key Findings
- U-shaped relationship between early pregnancy hemoglobin and SNM-M.
- Adjusted relative risk of SNM-M is 1.08 at 105 g/L and 1.17 at 90 g/L.
- Elevated hemoglobin levels also increase risk, with adjusted relative risks of 1.05 at 135 g/L and 1.20 at 150 g/L.
- Rate of SNM-M at the reference level of 125 g/L is 6.7%.
- Similar patterns observed for preterm birth and combined outcomes of SNM-M or stillbirth.
- Findings persist after adjusting for maternal body mass index and hyperemesis gravidarum.
Clinical Implications
Healthcare providers should monitor maternal hemoglobin levels early in pregnancy to identify those at risk for severe neonatal morbidity and mortality. This study suggests that both low and high hemoglobin levels warrant attention and potential intervention to improve neonatal outcomes.
Conclusion
The findings from this large cohort study emphasize the critical role of early pregnancy hemoglobin levels in predicting neonatal health risks. Monitoring and managing hemoglobin concentration could be vital in enhancing maternal and infant health outcomes.
References
- Annals of Internal Medicine, 2026 -- When Hemoglobin Signals Neonatal Risk
- Pediatric Cardiology — Peripheral Perfusion Index: Normative Values from Electronically Reported CCHD Screening
- Intensive Care Medicine — Physiological determinants and the red blood cells transfusion decision-making process in non-bleeding critically ill patients: a comprehensive narrative review
- Journal of Medical Internet Research (JMIR) — A Chatbot to Meet Parents’ Information Needs for Sickle Cell Trait Newborn Screening Results: Multiple Methods Formative Study
- Pediatric Cardiology — Cardiac Troponin T Levels in Healthy Term Neonates
- Maternal anemia, erythrocytosis linked to neonatal morbidity and mortality
- Executive summary - Guideline on haemoglobin cutoffs to define anaemia in individuals and populations
- Assessment and
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
